πŸ‡ΊπŸ‡Έ FDA
Patent

US 8343549

Therapeutic uses of Dunaliella powder

granted A61KA61K31/192A61K31/216

Quick answer

US patent 8343549 (Therapeutic uses of Dunaliella powder) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/192, A61K31/216, A61K31/426, A61K31/427